Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives
Bruno Almeida Costa, Tarek H. Mouhieddine, Ricardo J. Ortiz, Joshua Richter
Topics & Concepts
BendamustineCyclophosphamideMultiple myelomaMedicineMelphalanOncologyMonoclonal antibodyChimeric antigen receptorBlinatumomabChemotherapyImmunologyAntibodyInternal medicineCancer researchRituximabImmunotherapyCancerCD19Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsMonoclonal and Polyclonal Antibodies Research